Dr. Rodriguez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5439 Ray Ellison Blvd
San Antonio, TX 78242- Is this information wrong?
Summary
- Dr. Maria Rodriguez is a pediatrician in San Antonio, TX.
Education & Training
- University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 1983 - 1986
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 1979 - 1982
- McGovern Medical School at UTHealthClass of 1979
Certifications & Licensure
- FL State Medical License 2021 - Present
- AZ State Medical License 2023 - 2026
- TN State Medical License 2023 - 2025
- WA State Medical License 2023 - 2025
- OK State Medical License 2020 - 2025
- AL State Medical License 2023 - 2024
- TX State Medical License 2013 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 2001
Clinical Trials
- Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma Start of enrollment: 2005 Sep 01
Publications & Presentations
PubMed
- Real-world analysis of safety and efficacy of CAR T-cell therapy in lymphoma patients with decreased kidney function.Omar Mamlouk, Paolo Strati, Lei Feng, Ryan Sun, Amy Ayers, Raphael E Steiner, Ranjit Nair, Christopher Flowers, Jeremy L Ramdial, Neeraj Saini, Samer A Srour, Richard ...> ;British Journal of Haematology. 2024 Jan 1
- 5 citationsA phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma.Paolo Strati, Andrew Jallouk, Qing Deng, Xubin Li, Lei Feng, Ryan Sun, Sherry Adkins, Swapna Johncy, Taylor Cain, Raphael E Steiner, Sairah Ahmed, Dai Chihara, Luis E ...> ;Blood Advances. 2023 Nov 14
- 5 citationsA phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL.Hua-Jay J Cherng, Stefan K Alig, Yasuhiro Oki, Loretta J Nastoupil, Luis Fayad, Sattva S Neelapu, Francesco Turturro, Fredrick Hagemeister, Alexander F M Craig, Charle...> ;Blood Advances. 2023 Apr 11
- Join now to see all
Abstracts/Posters
- A Phase II Trial of Nivolumab and Ibrutinib for Patients with Relapsed or Refractory Central Nervous System LymphomaMaria Alma Rodriguez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Smart Start: Rituximab, Lenalidomide, and Ibrutinib Alone and in Combination with Standard Chemotherapy for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma...Maria Alma Rodriguez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Radiation Therapy Can be an Effective Bridging Strategy Prior to Axicabtagene Ciloleucel Therapy for Relapsed/Refractory Large B-Cell LymphomaRadiation Therapy Can be ...Maria Alma Rodriguez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Professional Memberships
- Member
- Fellow
Hospital Affiliations
- University of Texas M.D. Anderson Cancer CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: